| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |